Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
Phase 2
150
about 6 years
18–70
1 site in CT
What this study is about
Researchers are testing whether Prazosin (16mg/day) helps people with alcohol use disorder and withdrawal symptoms. Participants will receive weekly counseling to support their recovery, along with either Prazosin or a placebo medication over 12 weeks. The trial will also assess drinking patterns like heavy drinking days and no heavy drinking days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in 12-Step Facilitation with Relapse Prevention and Contingency Management
- 2.Take Prazosin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
prazosin (Alpha-1 blocker; relaxes blood vessels and prostate)
oral (Oral Capsule)
Psychiatry / Mental Health